Masthead-Image-Right-min

RCM Automation: Where to Focus or Further Refine

COVID-19 continues to disrupt healthcare delivery, which will pose financial challenges to both large and small organizations. Now is the right time to investigate automation to keep revenue flowing and optimize reimbursements.

Continue Reading...

Navigating Reimbursement for Liquid Biopsy Cancer Testing

Thirty-eight percent of private payers now cover some type of ctDNA-based panel testing. Is your lab aware of evolving payment policies?

Continue Reading...

COVID-19: Insurers Exempt from Covering Workplace Testing

Must Cover “Medically Appropriate” Tests Only

Continue Reading...

Protect Revenue Cycle Capabilities to Limit COVID-19 Fallout

Hospitals must be aware of operational issues that could negatively impact cash flow.

Continue Reading...

How to Receive Reimbursement for Uninsured COVID-19 Patients

Legislation enacted providing reimbursement for testing and treatment of uninsured COVID-19 patients.

Continue Reading...